Published in Mamm Genome on February 28, 2007
Chromatin remodelling during development. Nature (2010) 5.86
ATP-dependent chromatin remodeling: genetics, genomics and mechanisms. Cell Res (2011) 4.91
Open chromatin in pluripotency and reprogramming. Nat Rev Mol Cell Biol (2011) 2.69
Sox2 cooperates with Chd7 to regulate genes that are mutated in human syndromes. Nat Genet (2011) 2.56
Mutations in CHD7, encoding a chromatin-remodeling protein, cause idiopathic hypogonadotropic hypogonadism and Kallmann syndrome. Am J Hum Genet (2008) 2.33
Genomic distribution of CHD7 on chromatin tracks H3K4 methylation patterns. Genome Res (2009) 2.31
CHD7 targets active gene enhancer elements to modulate ES cell-specific gene expression. PLoS Genet (2010) 2.20
Molecular and phenotypic aspects of CHD7 mutation in CHARGE syndrome. Am J Med Genet A (2010) 1.82
Great vessel development requires biallelic expression of Chd7 and Tbx1 in pharyngeal ectoderm in mice. J Clin Invest (2009) 1.40
Chromatin remodeling in cardiovascular development and physiology. Circ Res (2011) 1.34
Histone H1 recruitment by CHD8 is essential for suppression of the Wnt-β-catenin signaling pathway. Mol Cell Biol (2011) 1.27
Epigenetic regulation in pluripotent stem cells: a key to breaking the epigenetic barrier. Philos Trans R Soc Lond B Biol Sci (2013) 1.26
Defects in neural stem cell proliferation and olfaction in Chd7 deficient mice indicate a mechanism for hyposmia in human CHARGE syndrome. Hum Mol Genet (2009) 1.26
The ATP-dependent chromatin remodeling enzyme CHD7 regulates pro-neural gene expression and neurogenesis in the inner ear. Development (2010) 1.24
Chromatin remodeling by the CHD7 protein is impaired by mutations that cause human developmental disorders. Proc Natl Acad Sci U S A (2012) 1.15
CHD7 functions in the nucleolus as a positive regulator of ribosomal RNA biogenesis. Hum Mol Genet (2010) 1.13
Inappropriate p53 activation during development induces features of CHARGE syndrome. Nature (2014) 1.04
Reproductive dysfunction and decreased GnRH neurogenesis in a mouse model of CHARGE syndrome. Hum Mol Genet (2011) 1.02
Study of smell and reproductive organs in a mouse model for CHARGE syndrome. Eur J Hum Genet (2009) 1.01
More Clinical Overlap between 22q11.2 Deletion Syndrome and CHARGE Syndrome than Often Anticipated. Mol Syndromol (2013) 1.00
Chromodomain proteins in development: lessons from CHARGE syndrome. Clin Genet (2010) 0.95
Mature middle and inner ears express Chd7 and exhibit distinctive pathologies in a mouse model of CHARGE syndrome. Hear Res (2011) 0.95
Xenopus: An emerging model for studying congenital heart disease. Birth Defects Res A Clin Mol Teratol (2011) 0.89
Delayed fusion and altered gene expression contribute to semicircular canal defects in Chd7 deficient mice. Mech Dev (2012) 0.89
Epigenetic regulation in neural crest development. Dev Biol (2014) 0.89
CHD7 and retinoic acid signaling cooperate to regulate neural stem cell and inner ear development in mouse models of CHARGE syndrome. Hum Mol Genet (2013) 0.87
CHD7 interacts with BMP R-SMADs to epigenetically regulate cardiogenesis in mice. Hum Mol Genet (2013) 0.84
The role of CHD7 and the newly identified WDR11 gene in patients with idiopathic hypogonadotropic hypogonadism and Kallmann syndrome. Mol Cell Endocrinol (2011) 0.83
Otitis media in a new mouse model for CHARGE syndrome with a deletion in the Chd7 gene. PLoS One (2012) 0.83
Architects of the genome: CHD dysfunction in cancer, developmental disorders and neurological syndromes. Epigenomics (2014) 0.82
Identification and characterization of FAM124B as a novel component of a CHD7 and CHD8 containing complex. PLoS One (2012) 0.82
Regulation of chromatin structure in the cardiovascular system. Circ J (2013) 0.81
Chromodomain helicase DNA-binding proteins in stem cells and human developmental diseases. Stem Cells Dev (2015) 0.81
Knockdown of fbxl10/kdm2bb rescues chd7 morphant phenotype in a zebrafish model of CHARGE syndrome. Dev Biol (2013) 0.81
CHD7 mutations and CHARGE syndrome in semicircular canal dysplasia. Otol Neurotol (2014) 0.81
Structural pituitary abnormalities associated with CHARGE syndrome. J Clin Endocrinol Metab (2013) 0.80
Chromatin remodeling in development and disease: focus on CHD7. PLoS Genet (2010) 0.80
Genetics of Combined Pituitary Hormone Deficiency: Roadmap into the Genome Era. Endocr Rev (2016) 0.80
NELF knockout is associated with impaired pubertal development and subfertility. Mol Cell Endocrinol (2015) 0.79
Epigenetic Developmental Disorders: CHARGE syndrome, a case study. Curr Genet Med Rep (2015) 0.79
CHD7 deficiency in "Looper", a new mouse model of CHARGE syndrome, results in ossicle malformation, otosclerosis and hearing impairment. PLoS One (2014) 0.78
A critical role for the chromatin remodeller CHD7 in anterior mesoderm during cardiovascular development. Dev Biol (2015) 0.78
Epigenetic regulation in the inner ear and its potential roles in development, protection, and regeneration. Front Cell Neurosci (2015) 0.77
The chromatin remodeling protein CHD7, mutated in CHARGE syndrome, is necessary for proper craniofacial and tracheal development. Dev Dyn (2014) 0.77
Different CHD chromatin remodelers are required for expression of distinct gene sets and specific stages during development of Dictyostelium discoideum. Development (2013) 0.77
Guilty as CHARGED: p53's expanding role in disease. Cell Cycle (2014) 0.77
Chd7 is indispensable for mammalian brain development through activation of a neuronal differentiation programme. Nat Commun (2017) 0.75
Rescue of neural crest-derived phenotypes in a zebrafish CHARGE model by Sox10 downregulation. Hum Mol Genet (2016) 0.75
Mouse Models for the Dissection of CHD7 Functions in Eye Development and the Molecular Basis for Ocular Defects in CHARGE Syndrome. Invest Ophthalmol Vis Sci (2015) 0.75
Ino80 is essential for proximal-distal axis asymmetry in part by regulating Bmp4 expression. BMC Biol (2016) 0.75
Harnessing Molecular Motors for Nanoscale Pulldown in Live Cells. Mol Biol Cell (2016) 0.75
Versatile Roles of the Chromatin Remodeler CHD7 during Brain Development and Disease. Front Mol Neurosci (2017) 0.75
Cooperation between complexes that regulate chromatin structure and transcription. Cell (2002) 10.38
Mutations in a new member of the chromodomain gene family cause CHARGE syndrome. Nat Genet (2004) 6.90
ATP-dependent nucleosome remodeling. Annu Rev Biochem (2001) 5.59
Chd1 chromodomain links histone H3 methylation with SAGA- and SLIK-dependent acetylation. Nature (2005) 5.15
Death before birth: clues from gene knockouts and mutations. Trends Genet (1995) 4.07
Characterization of the CHD family of proteins. Proc Natl Acad Sci U S A (1997) 3.76
Systematic identification of novel protein domain families associated with nuclear functions. Genome Res (2002) 3.50
Dosage requirement of Pitx2 for development of multiple organs. Development (1999) 3.08
CHARGE syndrome: the phenotypic spectrum of mutations in the CHD7 gene. J Med Genet (2005) 3.03
Influence of PAX6 gene dosage on development: overexpression causes severe eye abnormalities. Cell (1996) 3.01
Choanal atresia and associated multiple anomalies. J Pediatr (1979) 2.98
An epidemiological analysis of CHARGE syndrome: preliminary results from a Canadian study. Am J Med Genet A (2005) 2.74
The SANT domain: a unique histone-tail-binding module? Nat Rev Mol Cell Biol (2004) 2.63
Chromatin remodeling by ATP-dependent molecular machines. Bioessays (2003) 2.57
Spectrum of CHD7 mutations in 110 individuals with CHARGE syndrome and genotype-phenotype correlation. Am J Hum Genet (2005) 2.22
Congenital malformations of the inner ear: a classification based on embryogenesis. Laryngoscope (1987) 2.18
ATP-dependent chromatin remodeling. Curr Top Dev Biol (2005) 2.02
Identification and validation of PDGF transcriptional targets by microarray-coupled gene-trap mutagenesis. Nat Genet (2004) 1.85
Phenotypic spectrum of CHARGE syndrome in fetuses with CHD7 truncating mutations correlates with expression during human development. J Med Genet (2005) 1.80
The Drosophila kismet gene is related to chromatin-remodeling factors and is required for both segmentation and segment identity. Development (1999) 1.77
Multiple mutations in mouse Chd7 provide models for CHARGE syndrome. Hum Mol Genet (2005) 1.71
ATP-dependent nucleosome remodelling: factors and functions. J Cell Sci (2004) 1.68
CHARGE syndrome: report of 47 cases and review. Am J Med Genet (1998) 1.68
CHARGE Association in newborns: a registry-based study. Teratology (1999) 1.55
ATP-dependent nucleosome remodeling complexes: enzymes tailored to deal with chromatin. J Cell Biochem (2004) 1.46
Construction of a bifunctional mRNA in the mouse by using the internal ribosomal entry site of the encephalomyocarditis virus. Mol Cell Biol (1992) 1.46
Phenotypic spectrum of CHARGE syndrome with CHD7 mutations. J Pediatr (2006) 1.45
CHARGE syndrome includes hypogonadotropic hypogonadism and abnormal olfactory bulb development. J Clin Endocrinol Metab (2005) 1.28
Mutation of the SNF2 family member Chd2 affects mouse development and survival. J Cell Physiol (2006) 1.23
Descriptive and experimental analysis of the epithelial remodellings that control semicircular canal formation in the developing mouse inner ear. Dev Biol (1993) 1.19
Nestin-Cre mediated deletion of Pitx2 in the mouse. Genesis (2006) 1.18
Pitx2 distinguishes subtypes of terminally differentiated neurons in the developing mouse neuroepithelium. Dev Biol (2002) 1.13
Insertional mutagenesis by retroviruses and promoter traps in embryonic stem cells. Methods Enzymol (1993) 1.11
Congenital aplasia of the semicircular canals. Otol Neurotol (2003) 1.08
ENU mutagenesis reveals a highly mutable locus on mouse Chromosome 4 that affects ear morphogenesis. Mamm Genome (2002) 1.03
Epidemiology of choanal atresia with special reference to the CHARGE association. Pediatrics (1997) 0.98
Gene trap mutagenesis in embryonic stem cells. Methods Enzymol (2003) 0.92
Characterization and functional analysis of CReMM, a novel chromodomain helicase DNA-binding protein. J Mol Biol (2005) 0.91
Two new mouse mutants with vestibular defects that map to the highly mutable locus on chromosome 4. Int J Audiol (2005) 0.90
Characterization of a new mouse mutant, flouncer, with a balance defect and inner ear malformation. Otol Neurotol (2004) 0.88
The Wheels mutation in the mouse causes vascular, hindbrain, and inner ear defects. Dev Biol (2001) 0.88
Heterozygosity mapping of partially congenic lines: mapping of a semidominant neurological mutation, Wheels (Whl), on mouse chromosome 4. Genetics (1995) 0.83
Growth failure and pituitary function in CHARGE and VATER associations. Arch Dis Child (1999) 0.81
Mutagenesis and behavioral screening for altered circadian activity identifies the mouse mutant, Wheels. Brain Res (1995) 0.77
Multiple recurrent de novo CNVs, including duplications of the 7q11.23 Williams syndrome region, are strongly associated with autism. Neuron (2011) 10.61
Auditory hair cell replacement and hearing improvement by Atoh1 gene therapy in deaf mammals. Nat Med (2005) 5.17
Phenotypic heterogeneity of genomic disorders and rare copy-number variants. N Engl J Med (2012) 4.36
A multisite study of the clinical diagnosis of different autism spectrum disorders. Arch Gen Psychiatry (2011) 2.99
Common genetic variants, acting additively, are a major source of risk for autism. Mol Autism (2012) 2.67
Math1 gene transfer generates new cochlear hair cells in mature guinea pigs in vivo. J Neurosci (2003) 2.67
Claudin 14 knockout mice, a model for autosomal recessive deafness DFNB29, are deaf due to cochlear hair cell degeneration. Hum Mol Genet (2003) 2.36
COQ6 mutations in human patients produce nephrotic syndrome with sensorineural deafness. J Clin Invest (2011) 2.21
Molecular and phenotypic aspects of CHD7 mutation in CHARGE syndrome. Am J Med Genet A (2010) 1.82
PITX2, beta-catenin and LEF-1 interact to synergistically regulate the LEF-1 promoter. J Cell Sci (2005) 1.58
Characterization of progenitor domains in the developing mouse thalamus. J Comp Neurol (2007) 1.55
Identification and characterization of choline transporter-like protein 2, an inner ear glycoprotein of 68 and 72 kDa that is the target of antibody-induced hearing loss. J Neurosci (2004) 1.48
Glial cell line-derived neurotrophic factor and chronic electrical stimulation prevent VIII cranial nerve degeneration following denervation. J Comp Neurol (2002) 1.42
Response of the flat cochlear epithelium to forced expression of Atoh1. Hear Res (2008) 1.40
Duplication 16p11.2 in a child with infantile seizure disorder. Am J Med Genet A (2010) 1.30
Transgenic BDNF induces nerve fiber regrowth into the auditory epithelium in deaf cochleae. Exp Neurol (2010) 1.29
Spontaneous hair cell regeneration in the mouse utricle following gentamicin ototoxicity. Hear Res (2008) 1.28
Gene transfer into supporting cells of the organ of Corti. Hear Res (2002) 1.25
The ATP-dependent chromatin remodeling enzyme CHD7 regulates pro-neural gene expression and neurogenesis in the inner ear. Development (2010) 1.24
Mutation of the novel gene Tmie results in sensory cell defects in the inner ear of spinner, a mouse model of human hearing loss DFNB6. Hum Mol Genet (2002) 1.24
The fate of outer hair cells after acoustic or ototoxic insults. Hear Res (2006) 1.20
Nasal saline for chronic sinonasal symptoms: a randomized controlled trial. Arch Otolaryngol Head Neck Surg (2007) 1.18
Nestin-Cre mediated deletion of Pitx2 in the mouse. Genesis (2006) 1.18
BMP4 loss-of-function mutations in developmental eye disorders including SHORT syndrome. Hum Genet (2011) 1.18
Effects of hearing preservation on psychophysical responses to cochlear implant stimulation. J Assoc Res Otolaryngol (2009) 1.17
Autosomal dominant stapes ankylosis with broad thumbs and toes, hyperopia, and skeletal anomalies is caused by heterozygous nonsense and frameshift mutations in NOG, the gene encoding noggin. Am J Hum Genet (2002) 1.16
PITX2 is required for normal development of neurons in the mouse subthalamic nucleus and midbrain. Dev Biol (2004) 1.15
Antioxidant gene therapy can protect hearing and hair cells from ototoxicity. Mol Ther (2004) 1.15
CHD7 functions in the nucleolus as a positive regulator of ribosomal RNA biogenesis. Hum Mol Genet (2010) 1.13
Cochlear implants and ex vivo BDNF gene therapy protect spiral ganglion neurons. Hear Res (2007) 1.12
Over-expression of BDNF by adenovirus with concurrent electrical stimulation improves cochlear implant thresholds and survival of auditory neurons. Hear Res (2008) 1.11
Adjusting head circumference for covariates in autism: clinical correlates of a highly heritable continuous trait. Biol Psychiatry (2013) 1.11
Adenovirus-mediated expression of brain-derived neurotrophic factor protects spiral ganglion neurons from ototoxic damage. Audiol Neurootol (2004) 1.10
Nestin-lineage cells contribute to the microvasculature but not endocrine cells of the islet. Diabetes (2003) 1.08
Gene therapy in the inner ear using adenovirus vectors. Adv Otorhinolaryngol (2009) 1.07
Notch signaling and Hes labeling in the normal and drug-damaged organ of Corti. Hear Res (2009) 1.07
Cell division and maintenance of epithelial integrity in the deafened auditory epithelium. Cell Cycle (2007) 1.07
Detection of pulse trains in the electrically stimulated cochlea: effects of cochlear health. J Acoust Soc Am (2011) 1.06
Defects in vestibular sensory epithelia and innervation in mice with loss of Chd7 function: implications for human CHARGE syndrome. J Comp Neurol (2007) 1.06
Deafness and permanently reduced potassium channel gene expression and function in hypothyroid Pit1dw mutants. J Neurosci (2009) 1.04
Clinical characterization of individuals with deletions of genes in holoprosencephaly pathways by aCGH refines the phenotypic spectrum of HPE. Hum Genet (2010) 1.03
Myo15 function is distinct from Myo6, Myo7a and pirouette genes in development of cochlear stereocilia. Hum Mol Genet (2003) 1.02
Dietary thyroid hormone replacement ameliorates hearing deficits in hypothyroid mice. Mamm Genome (2007) 1.02
Reproductive dysfunction and decreased GnRH neurogenesis in a mouse model of CHARGE syndrome. Hum Mol Genet (2011) 1.02
Manipulating cell cycle regulation in the mature cochlea. Hear Res (2007) 1.01
Hearing and hair cells are protected by adenoviral gene therapy with TGF-beta1 and GDNF. Mol Ther (2003) 0.99
Localized cell and drug delivery for auditory prostheses. Hear Res (2008) 0.99
Cochlear infrastructure for electrical hearing. Hear Res (2011) 0.97
The use of neurotrophin therapy in the inner ear to augment cochlear implantation outcomes. Anat Rec (Hoboken) (2012) 0.97
Regulation of spinal interneuron development by the Olig-related protein Bhlhb5 and Notch signaling. Development (2011) 0.97
p27(Kip1) deficiency causes organ of Corti pathology and hearing loss. Hear Res (2006) 0.96
Notch signaling and Atoh1 expression during hair cell regeneration in the mouse utricle. Hear Res (2010) 0.96
Mature middle and inner ears express Chd7 and exhibit distinctive pathologies in a mouse model of CHARGE syndrome. Hear Res (2011) 0.95
Protein kinase C phosphorylation modulates N- and C-terminal regulatory activities of the PITX2 homeodomain protein. Biochemistry (2005) 0.95
Expression of p53 and Bcl-xL as predictive markers for larynx preservation in advanced laryngeal cancer. Arch Otolaryngol Head Neck Surg (2008) 0.94
Whirler mutant hair cells have less severe pathology than shaker 2 or double mutants. J Assoc Res Otolaryngol (2007) 0.93
Gene therapy for the inner ear. Hear Res (2012) 0.93
Chronic excitotoxicity in the guinea pig cochlea induces temporary functional deficits without disrupting otoacoustic emissions. J Acoust Soc Am (2004) 0.93
Reversible electrocochleographic abnormalities in superior canal dehiscence. Otol Neurotol (2009) 0.92
Modest impact on risk for autism spectrum disorder of rare copy number variants at 15q11.2, specifically breakpoints 1 to 2. Autism Res (2014) 0.90
Disruption of RAB40AL function leads to Martin--Probst syndrome, a rare X-linked multisystem neurodevelopmental human disorder. J Med Genet (2012) 0.90
Mutations in Grxcr1 are the basis for inner ear dysfunction in the pirouette mouse. Am J Hum Genet (2010) 0.90
Nerve maintenance and regeneration in the damaged cochlea. Hear Res (2011) 0.90
A novel chromosome 19p13.12 deletion in a child with multiple congenital anomalies. Am J Med Genet A (2009) 0.90
Induction of lysosomal phospholipase A2 through the retinoid X receptor in THP-1 cells. J Lipid Res (2004) 0.89
Delayed fusion and altered gene expression contribute to semicircular canal defects in Chd7 deficient mice. Mech Dev (2012) 0.89
The cytocaud: a hair cell pathology in the waltzing Guinea pig. Audiol Neurootol (2002) 0.88
The impact of serotonin transporter (5-HTTLPR) genotype on the development of resting-state functional connectivity in children and adolescents: a preliminary report. Neuroimage (2011) 0.88
siRNA targeting Hes5 augments hair cell regeneration in aminoglycoside-damaged mouse utricle. Mol Ther (2013) 0.88
CHD7 and retinoic acid signaling cooperate to regulate neural stem cell and inner ear development in mouse models of CHARGE syndrome. Hum Mol Genet (2013) 0.87
Future approaches for inner ear protection and repair. J Commun Disord (2010) 0.87
Branchiootorenal syndrome and oculoauriculovertebral spectrum features associated with duplication of SIX1, SIX6, and OTX2 resulting from a complex chromosomal rearrangement. Am J Med Genet A (2008) 0.86
The role of bone morphogenetic protein 4 in inner ear development and function. Hear Res (2006) 0.86
A glucocorticoid reduces adverse effects of adenovirus vectors in the cochlea. Audiol Neurootol (2003) 0.85
Characterization of two transgene insertional mutations at pirouette, a mouse deafness locus. Audiol Neurootol (2004) 0.84
Leigh syndrome in a girl with a novel DLD mutation causing E3 deficiency. Pediatr Neurol (2013) 0.84
Differential Gene Expression Following Noise Trauma in Birds and Mammals. Noise Health (2001) 0.84
Cre fate mapping reveals lineage specific defects in neuronal migration with loss of Pitx2 function in the developing mouse hypothalamus and subthalamic nucleus. Mol Cell Neurosci (2007) 0.84
WDR1 colocalizes with ADF and actin in the normal and noise-damaged chick cochlea. J Comp Neurol (2002) 0.84
Transgene expression in neonatal mouse inner ear explants mediated by first and advanced generation adenovirus vectors. Hear Res (2002) 0.83
Characterization of a stapes ankylosis family with a NOG mutation. Otol Neurotol (2003) 0.82
The use of a dual PEDOT and RGD-functionalized alginate hydrogel coating to provide sustained drug delivery and improved cochlear implant function. Biomaterials (2011) 0.82
Hyaluronic acid enhances gene delivery into the cochlea. Hum Gene Ther (2012) 0.82
Brain glutamine by MRS in a patient with urea cycle disorder and coma. Pediatr Neurol (2005) 0.82
Long-term effects of acoustic trauma on electrically evoked otoacoustic emission. J Assoc Res Otolaryngol (2005) 0.81
CHD7 mutations and CHARGE syndrome in semicircular canal dysplasia. Otol Neurotol (2014) 0.81
TNF-α, IFN-γ, IL-10, and IL-4 levels were elevated in a murine model of human sickle cell anemia maintained on a high protein/calorie diet. Exp Biol Med (Maywood) (2013) 0.81
Gene-based therapy for inner ear disease. Noise Health (2001) 0.81
Distinct populations of GABAergic neurons in mouse rhombomere 1 express but do not require the homeodomain transcription factor PITX2. Mol Cell Neurosci (2011) 0.81
Chromodomain helicase DNA-binding proteins in stem cells and human developmental diseases. Stem Cells Dev (2015) 0.81
Transdifferentiation and its applicability for inner ear therapy. Hear Res (2006) 0.81
Hearing dysfunction in heterozygous Mitf(Mi-wh) /+ mice, a model for Waardenburg syndrome type 2 and Tietz syndrome. Pigment Cell Melanoma Res (2012) 0.81
Age-related changes in cochlear gene expression in normal and shaker 2 mice. J Assoc Res Otolaryngol (2006) 0.80